A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- DRUG: Elranatamab
- DRUG: Carfilzomib
- DRUG: Maplirpacept
Sponsor
Pfizer